Stocks and Investing Stocks and Investing
Wed, January 18, 2023

Liisa Bayko Maintained (ALT) at Buy with Increased Target to $25 on, Jan 18th, 2023


Published on 2024-10-28 00:58:34 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Altimmune, Inc." (ALT) at Buy with Increased Target from $14 to $25 on, Jan 18th, 2023.

Liisa has made no other calls on ALT in the last 4 months.



There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Liisa


  • Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $20 on, Thursday, December 1st, 2022
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $26 on, Friday, November 11th, 2022

Contributing Sources